Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the

Qian Zhang1, Haikuo Zheng1, Zhongfan Zhang1

  • 1China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

PubMed

Insights

Left ventricular thrombus (LVT) poses stroke risks, necessitating better diagnosis and management. This review explores LVT pathophysiology, imaging, and novel direct oral anticoagulant treatments.

Area of Science:

  • Cardiology
  • Thrombosis
  • Medical Imaging

Background:

  • Left ventricular thrombus (LVT) is linked to stroke and systemic embolism, yet its management remains evidence-limited.
  • Understanding LVT pathophysiology and improving diagnostic accuracy are crucial for effective intervention.
  • Standard imaging modalities may underestimate LVT, contributing to delayed diagnosis and treatment.

Purpose of the Study:

  • To provide a comprehensive educational review of left ventricular thrombus.
  • To discuss LVT pathophysiology, diagnostic approaches, and modern treatment strategies.
  • To propose a management algorithm and highlight future research needs.

Main Methods:

  • Review of current literature on LVT pathophysiology, diagnosis, and treatment.
  • Analysis of echocardiographic and multimodality imaging techniques for LVT detection.
  • Evaluation of existing guidelines and expert consensus on LVT management.
  • Discussion of direct oral anticoagulants (OACs) in the context of LVT.

Main Results:

  • LVT is associated with significant embolic risks, underscoring the need for accurate diagnosis.
  • Echocardiography and multimodality imaging play key roles in LVT assessment.
  • Direct oral anticoagulants (OACs) show promise in LVT management with early safety and efficacy.
  • An algorithm for LVT prevention and treatment is proposed based on current evidence.

Conclusions:

  • Accurate diagnosis and understanding of LVT pathophysiology are essential for effective patient management.
  • Multimodality imaging enhances LVT detection and characterization.
  • Direct oral anticoagulants represent a significant advancement in LVT treatment strategies.
  • Further research is needed for robust risk stratification in LVT patients.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...